ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,094.70
-0.57%
S&P ASX All Technology
3,747.70
0.46%
Brent Oil
69.405
0.20%
US Dollar vs AUD
1.57847
0.04%
Bitcoin
90,980.43
0.38%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bicara Therapeutics Inc (BCAX) Share Price

Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

NASDAQ
14.88
1.21
(8.85%)
Closed 06 March 8:00AM
Delayed by 15 minutes
14.88
0.00
( 0.00% )
Pre Market: 8:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
14.88
Bid
13.16
Offer
21.00
Volume
-
0.00 Day's Range 0.00
11.10 52 Week Range 27.95
Market Cap
809.704M
Previous Close
14.88
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
449,993
Shares Outstanding
54,415,619
Dividend Yield
-
PE Ratio
-15.58
Earnings Per Share (EPS)
-0.96
Revenue
-
Net Profit
-51.99M

About Bicara Therapeutics Inc

Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor... Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, or HNSCC, where there remains a significant unmet need. We intend to initiate a pivotal Phase 2/3 trial of ficerafusp alfa in combination with pembrolizumab as a first-line therapy in recurrent/metastatic HNSCC excluding HPV-positive patients with oropharyngeal squamous cell carcinoma late in the fourth quarter of 2024 or early in the first quarter of 2025. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.bicara.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Bicara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BCAX. The last closing price for Bicara Therapeutics was US$14.88. Over the last year, Bicara Therapeutics shares have traded in a share price range of US$ 11.10 to US$ 27.95.

Bicara Therapeutics currently has 54,415,619 shares in issue. The market capitalisation of Bicara Therapeutics is US$809.70 million. Bicara Therapeutics has a price to earnings ratio (PE ratio) of -15.58.

Ask ADVFN Intelligence (AI)

BCAX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
14 January 2025
BCAX (8.85%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 November 2024
BCAX (8.85%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.5620.779220779212.3214.9311.76528916213.51172886CS
41.047.5144508670513.8414.9311.6434433413.03446568CS
12-4.73-24.120346761919.6120.708711.144999314.86516921CS
26-11.37-43.314285714326.2527.9511.141276618.47209413CS
52-11.37-43.314285714326.2527.9511.141276618.47209413CS
156-11.37-43.314285714326.2527.9511.141276618.47209413CS
260-11.37-43.314285714326.2527.9511.141276618.47209413CS

BCAX - Frequently Asked Questions (FAQ)

What is the current Bicara Therapeutics share price?
The current share price of Bicara Therapeutics is US$ 14.88
How many Bicara Therapeutics shares are in issue?
Bicara Therapeutics has 54,415,619 shares in issue
What is the market cap of Bicara Therapeutics?
The market capitalisation of Bicara Therapeutics is USD 809.7M
What is the 1 year trading range for Bicara Therapeutics share price?
Bicara Therapeutics has traded in the range of US$ 11.10 to US$ 27.95 during the past year
What is the PE ratio of Bicara Therapeutics?
The price to earnings ratio of Bicara Therapeutics is -15.58
What is the reporting currency for Bicara Therapeutics?
Bicara Therapeutics reports financial results in USD
What is the latest annual profit for Bicara Therapeutics?
The latest annual profit of Bicara Therapeutics is USD -51.99M
What is the registered address of Bicara Therapeutics?
The registered address for Bicara Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Bicara Therapeutics website address?
The website address for Bicara Therapeutics is www.bicara.com
Which industry sector does Bicara Therapeutics operate in?
Bicara Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 77.5761
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.21
(0.00%)
0
AACGATA Creativity Global
US$ 0.8244
(0.00%)
0
AACBUArtius II Acquisition Inc
US$ 10.03
(0.00%)
0

Discussion

View Full Feed
CanItBThisEZ2Make CanItBThisEZ2Make 5 minutes ago
BEST SELLERS RANK (BSR) IS 381 53 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Yachts Yachts 8 minutes ago
More from GROK:

This came from a promotional publication from a mining company to promote their stock. What concerns many investors is they publish these glowing reports, but never actually get around to the nitty gritty of mining. Digging out some ore, refining it or having it refi
SDRC
SkeBallLarry SkeBallLarry 10 minutes ago
Andrew Tate taunts Gov. DeSantis after Florida launches >

criminal investigation: ‘Arrest me’ >
https://nypost.com/2025/03/05/us-news/andrew-tate-he-taunts-desantis-after-florida-launches-criminal-investigation/
SkeBallLarry SkeBallLarry 10 minutes ago
Andrew Tate taunts Gov. DeSantis after Florida launches >

criminal investigation: ‘Arrest me’ >
https://nypost.com/2025/03/05/us-news/andrew-tate-he-taunts-desantis-after-florida-launches-criminal-investigation/
SkeBallLarry SkeBallLarry 11 minutes ago
Andrew Tate taunts Gov. DeSantis after Florida launches >

criminal investigation: ‘Arrest me’ >
https://nypost.com/2025/03/05/us-news/andrew-tate-he-taunts-desantis-after-florida-launches-criminal-investigation/
SkeBallLarry SkeBallLarry 11 minutes ago
Andrew Tate taunts Gov. DeSantis after Florida launches >

criminal investigation: ‘Arrest me’ >
https://nypost.com/2025/03/05/us-news/andrew-tate-he-taunts-desantis-after-florida-launches-criminal-investigation/
Big Brother Big Brother 13 minutes ago
Yeah, I was about to put a bid in when I saw the whack, as I think .02's would be insanely cheap for this, however, the stock has traded so poorly in its entire trading history, I didn't even bother.
LGCP
SkeBallLarry SkeBallLarry 14 minutes ago
Stranded astronaut confirms Biden shot down Musk’s offer >

to bring pair home: ‘Absolutely factual’ >
https://nypost.com/2025/03/05/us-news/stranded-astronaut-confirms-biden-shot-down-musks-offer-to-bring-pair-home-absolutely-factual/
SkeBallLarry SkeBallLarry 15 minutes ago
Stranded astronaut confirms Biden shot down Musk’s offer >

to bring pair home: ‘Absolutely factual’ >
https://nypost.com/2025/03/05/us-news/stranded-astronaut-confirms-biden-shot-down-musks-offer-to-bring-pair-home-absolutely-factual/
SkeBallLarry SkeBallLarry 15 minutes ago
Stranded astronaut confirms Biden shot down Musk’s offer >

to bring pair home: ‘Absolutely factual’ >
https://nypost.com/2025/03/05/us-news/stranded-astronaut-confirms-biden-shot-down-musks-offer-to-bring-pair-home-absolutely-factual/
SkeBallLarry SkeBallLarry 15 minutes ago
Stranded astronaut confirms Biden shot down Musk’s offer >

to bring pair home: ‘Absolutely factual’ >
https://nypost.com/2025/03/05/us-news/stranded-astronaut-confirms-biden-shot-down-musks-offer-to-bring-pair-home-absolutely-factual/
Yachts Yachts 17 minutes ago
I've been using GROK for some research on my books and I've found it useful. So, for fun I gave it a cut and paste of the salient portion of your post. Here's what GROK had to say:

Does It Ring True?
Yeah, it mostly does. The quote paints a picture of a rare, tricky ore that
SDRC
SkeBallLarry SkeBallLarry 21 minutes ago
Trump expected to sign executive order abolishing the >

Department of Education as soon as Thursday >
https://nypost.com/2025/03/05/us-news/trump-expected-to-sign-executive-order-abolishing-the-department-of-education/
SkeBallLarry SkeBallLarry 22 minutes ago
Trump expected to sign executive order abolishing the >

Department of Education as soon as Thursday >
https://nypost.com/2025/03/05/us-news/trump-expected-to-sign-executive-order-abolishing-the-department-of-education/
SkeBallLarry SkeBallLarry 22 minutes ago
Trump expected to sign executive order abolishing the >

Department of Education as soon as Thursday >
https://nypost.com/2025/03/05/us-news/trump-expected-to-sign-executive-order-abolishing-the-department-of-education/
SkeBallLarry SkeBallLarry 22 minutes ago
Trump expected to sign executive order abolishing the >

Department of Education as soon as Thursday >
https://nypost.com/2025/03/05/us-news/trump-expected-to-sign-executive-order-abolishing-the-department-of-education/
SkeBallLarry SkeBallLarry 24 minutes ago
Trump expected to sign executive order abolishing the >

Department of Education as soon as Thursday >
https://nypost.com/2025/03/05/us-news/trump-expected-to-sign-executive-order-abolishing-the-department-of-education/
elks elks 26 minutes ago
Yea 10 cent pass should be a given here. Gvsi
GVSI
elks elks 31 minutes ago
Give me. 10. GV.
GV
Seminole Red Seminole Red 33 minutes ago
https://scontent-mia3-3.xx.fbcdn.net/v/t39.30808-6/481480719_987512600144418_2190393473355075201_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=127cfc&_nc_ohc=EBBGizwR9WgQ7kNvgFgaVah&_nc_oc=AdiGAltt3RReq6HTCuijQmYlSDgZPtmAgDbgsZO-4kppXvDaDLBo7dcCTVBLo8rGcPhz5aLGeXmDPKsdQ0T9ZxGy&_nc_zt=23&_nc_ht=scontent-mia3-3.x
PJ3000 PJ3000 35 minutes ago
$104m annual sales reported March 2025, and $2m daily sales reported in Sep 2024, ca. 180 days before. At the same time it's 1650% growth, even 1700. Please tell me this is not cherry-picking and not a platform.

https://www.globenewswire.com/news-release/2025/03/03/3035792/0/en/Olived
OLVI
SilkRoad SilkRoad 35 minutes ago
The longer we go into 2025 with no production update the more it feels like Groundhog Day all over again. Let’s get moving KBLB!
https://investorshub.advfn.com/uimage/uploads/2025/3/6/osefqIMG_4531.jpeg
KBLB
againstallodds againstallodds 39 minutes ago
No significant short positions uncovered

Paig social promo clowns trying to use that old trick

No uncovered = No short squeeze

From OTC

https://investorshub.advfn.com/uimage/uploads/2025/3/6/rcmnhIMG_0326.jpeg
NBRI
havnagoodtime havnagoodtime 43 minutes ago
You could request a review, if you want.
HMBL
sam1933 sam1933 45 minutes ago
Neuron Goes Live on Hedera to Prevent Aerial Disasters
[pre]After a tragic plane-helicopter collision killed 67,
aviation safety is in focus.[/pre]

https://www.altcoinbuzz.io/cryptocurrency-news/neuron-goes-live-on-hedera-to-prevent-aerial-disasters/
HBARUSD

Your Recent History

NASDAQ
BCAX
Bicara Therapeutics
COIN
ANSSGBP
ANS CRYPTO COIN
NASDAQ
AONCW
American Oncology Network
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads